European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

A smart hyperspectral system for early, non-invasive diagnosis of retinal disease

Descrizione del progetto

Una nuova diagnostica per immagini per la malattia della retina

I progressi compiuti nel campo dell’imaging per la retina sono essenziali per la comprensione e il trattamento delle patologie oculari. Il progetto XpeFundus, finanziato dall’UE, si concentra sulla diagnostica per immagini intesa a sviluppare una nuova telecamera iperspettrale per la visualizzazione del fondo oculare (la superficie interna dell’occhio opposta al cristallino che comprende la retina, il disco ottico, la macula, la fovea e il polo posteriore). Questa telecamera innovativa è uno strumento di diagnostica completo, dotato di un software di visualizzazione basato sull’intelligenza artificiale, che non solo consente una valutazione clinica rapida e non invasiva delle malattie della retina, ma potrebbe dimostrarsi inoltre prezioso per il trattamento laser, per scopi didattici e per la ricerca medica.

Obiettivo

The future of retinal diagnostics relies on data-backed smart devices that can see beyond the human eye. With a rising incidence of eye-related diseases further aggravated by the diabetes pandemic, early diagnosis and treatment could prevent up to 98% of sight loss resulting from diabetes. Advances in retinal imaging are in fact fundamental to our understanding and treatment of ocular diseases. XpectralTEK is a European startup focused on the development of imaging diagnostics that aim to improve the visualisation of objects, nature and the human body. By leveraging our expertise in spectroscopy, imaging and computer vision we developed a new hyperspectral fundus camera, XpeFundus. Our camera is capable to perform in-vivo retinal spectroscopy without excessive irradiation making the extreme light intensities and invasive diagnostic methods completely redundant and radically improving the patient experience. Through 3x improved visual mapping of eye tissue alterations, the doctor makes an earlier diagnosis of retinal pathology which leads to earlier prognosis and treatment. Backed by an AI-powered visualisation software and VR, our camera is a complete diagnostic tool that empowers ophthalmologists towards the rapid and non-invasive clinical evaluation of retinal diseases but can also prove a valuable tool for laser treatment, future doctor education and medical research.
With the Global Fundus Cameras Market poised to reach a value of $743.3 million by 2025, we are confident that XpeFundus is coming to the market at the right time. Due to the increasing prevalence of eye disorders but also the stagnated number of new ophthalmologists entering the field, advances in retinal diagnostics are a global market high priority. We have already successfully commercialised our patented prototype for its application in cultural heritage and agriculture and we are confident that our business and medical background will be strong assets to bring XpeFundus to the medical market.

Invito a presentare proposte

H2020-EIC-SMEInst-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-SMEInst-2018-2020-1

Meccanismo di finanziamento

SME-1 - SME instrument phase 1

Coordinatore

XPECTRALTEK, LDA
Contribution nette de l'UE
€ 50 000,00
Indirizzo
TRAVESSA DOS PRADOS 12
4705-827 Braga
Portogallo

Mostra sulla mappa

PMI

L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.

Regione
Continente Norte Cávado
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
€ 71 429,00